Market revenue in 2022 | USD 495.1 million |
Market revenue in 2030 | USD 739.5 million |
Growth rate | 5.1% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 93.9% in 2024. Horizon Databook has segmented the Germany menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
In Germany, dietary supplements are scrutinized for efficacy and safety by Commission E, a part of the German Federal Institute for Drugs and Medical Devices. Commission E has approved black cohosh (the brand Remifemin), 40 mg/day for six months for dysmenorrhea, Premenstrual Syndrome (PMS), and menopausal symptoms. Increasing awareness about the use of dietary supplements in easing menopause symptoms, along with the availability of approved dietary supplements, can positively impact market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account